Home » Topics » Regulatory

Regulatory
RSS

Esmya approved in Europe

Feb. 27, 2012

European Commission approves Glivec label update

Feb. 27, 2012

FDA grants first approval for drug-eluting coronary stent use in AMI

Feb. 23, 2012

BMS gains additional indication approvals for two anticancer drugs

Feb. 23, 2012

Line extension for Zyprexa approved in Japan

Feb. 23, 2012

Nippon Kayaku anticancer drugs approved for additional indications in Japan

Feb. 22, 2012

FDA approves first medical therapy for endogenous Cushing's syndrome

Feb. 20, 2012

Health Canada approves line extension for Prevnar 13

Feb. 17, 2012

FDA approves new gel for male hypogonadism

Feb. 16, 2012

Line extension for Vyvanse in U.S.

Feb. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...